LBP1 Interim results of an open-label, multicentre, Phase 1/2 study to assess YTB323 (rapcabtagene autoleucel), a CAR T-cell therapy, for severe refractory systemic lupus erythematosus
| Autor: | Giulio Cavalli, Julia Weinmann-Menke, Clive Drakeford, Mi Kwon, Peter Gergely, Tamas Shisha, Pere Barba, Eva Wagner-Drouet, Josefina Cortés Hernández, José María Álvaro-Gracia Álvaro, Ozana Fischer, Beata Kovacs, Frédérique Chaperon, David Pearson, Tiina Kirsilä, Chih-Yung Sean Lee |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2024 |
| Předmět: | |
| Zdroj: | Lupus Science and Medicine, Vol 11, Iss Suppl 1 (2024) |
| Druh dokumentu: | article |
| ISSN: | 2053-8790 |
| DOI: | 10.1136/lupus-2024-el.222 |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|